What is the story about?
Shares of Zota Health Care Ltd. are in focus on Thursday, December 18, after the company's fund raising committee approved the issue and allotment of 22.8 lakh equity shares to eligible qualified institutional buyers (QIBs) at the issue price of ₹1,535 per equity share., aggregating to ₹349.99 crore.
Here's a look at the funds who were issued the shares as part of the QIP process:
Among the QIP shares issued to fund houses, only Valiant Mauritius Partners Offshore Ltd. previously held 1.84% stake in the company at the end of the September quarter, as per data available on the National Stock Exchange (NSE).
Following the allotment under the qualified institutional placement (QIP), the paid-up equity share capital of Zota Health Care has increased from ₹30.89 crore comprising 3.08 crore equity shares to ₹33.17 crore, consisting of 3.31 crore equity shares, the company said.
Zota Health Care launched the QIP on December 15, and it closed on December 17, 2025. The company's fundraising committee had approved ₹1,615.28 per equity share as the floor price for the QIP.
Sources had told CNBC-TV18 that the indicative issue price was ₹1,535 per equity share and the company was looking at raising funds worth up to ₹400 crore via the QIP, including a green shoe option of ₹100 crore.
As per sources, Zota Health Care is set to use the proceeds for funding the working capital requirements of the firm, invest in Davaindia Health Mart Ltd. for capital expenditure towards setting up new COCO stores in India and for general corporate purposes.
Shares of Zota Health Care Ltd. ended the previous trade session 0.57% lower at ₹1,645 apiece. The stock has gained 106.4% this year, so far.
Also Read:Mahindra Lifespace shares in focus after launching ₹1,900 crore premium housing project in Bengaluru
Here's a look at the funds who were issued the shares as part of the QIP process:
| Fund Name | Shares Issued | % Of QIP |
| Valiant Mauritius Partners Offshore Ltd | 6.05 lakh | 26.57 |
| Valiant Mauritius Partners Ltd | 3.71 lakh | 16.29 |
| Ashoka Whiteoak ICAV - Ashoka Whiteoak India Opportunities Fund | 2.65 lakh | 11.65 |
| Whiteoak Capital Special Opportunities Fund | 1.3 lakh | 5.71 |
| Whiteoak Capital Pharma | ||
| Sanshi Fund-I | 1.62 lakh | 7.14 |
| Turnaround Opportunities Fund | 1.14 lakh | 5 |
Among the QIP shares issued to fund houses, only Valiant Mauritius Partners Offshore Ltd. previously held 1.84% stake in the company at the end of the September quarter, as per data available on the National Stock Exchange (NSE).
Following the allotment under the qualified institutional placement (QIP), the paid-up equity share capital of Zota Health Care has increased from ₹30.89 crore comprising 3.08 crore equity shares to ₹33.17 crore, consisting of 3.31 crore equity shares, the company said.
Zota Health Care launched the QIP on December 15, and it closed on December 17, 2025. The company's fundraising committee had approved ₹1,615.28 per equity share as the floor price for the QIP.
Sources had told CNBC-TV18 that the indicative issue price was ₹1,535 per equity share and the company was looking at raising funds worth up to ₹400 crore via the QIP, including a green shoe option of ₹100 crore.
As per sources, Zota Health Care is set to use the proceeds for funding the working capital requirements of the firm, invest in Davaindia Health Mart Ltd. for capital expenditure towards setting up new COCO stores in India and for general corporate purposes.
Shares of Zota Health Care Ltd. ended the previous trade session 0.57% lower at ₹1,645 apiece. The stock has gained 106.4% this year, so far.
Also Read:Mahindra Lifespace shares in focus after launching ₹1,900 crore premium housing project in Bengaluru
